{"id":"NCT01852045","sponsor":"Allergan","briefTitle":"Study of OnabotulinumtoxinA (BOTOX速) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients","officialTitle":"BOTOX速 in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-02","primaryCompletion":"2018-10-11","completion":"2018-10-11","firstPosted":"2013-05-13","resultsPosted":"2019-10-30","lastUpdate":"2019-11-21"},"enrollment":114,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Incontinence"],"interventions":[{"type":"BIOLOGICAL","name":"OnabotulinumtoxinA","otherNames":["BOTOX速","botulinum toxin Type A"]}],"arms":[{"label":"OnabotulinumtoxinA 50 U","type":"EXPERIMENTAL"},{"label":"OnabotulinumtoxinA 100 U","type":"EXPERIMENTAL"},{"label":"OnabotulinumtoxinA 200 U","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the 3 doses of onabotulinumtoxinA (botulinum toxin Type A) for the treatment of urinary incontinence due to neurogenic detrusor overactivity in pediatric participants between the ages of 5 to 17 years to determine if 1 or more doses were safe and effective.","primaryOutcome":{"measure":"Change From Baseline in Daily Average Frequency of Daytime Urinary Incontinence Episodes","timeFrame":"Baseline (Day -28 to Day -1) to 2 consecutive days prior to Week 6","effectByArm":[{"arm":"OnabotulinumtoxinA 50 U","deltaMin":-1.3,"sd":0.205},{"arm":"OnabotulinumtoxinA 100 U","deltaMin":-1.3,"sd":0.189},{"arm":"OnabotulinumtoxinA 200 U","deltaMin":-1.34,"sd":0.245}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9949"},{"comp":"OG000 vs OG002","p":"0.9123"}]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":31,"countries":["United States","Belgium","Canada","Czechia","France","Italy","Poland","Turkey (T端rkiye)"]},"refs":{"pmids":[],"seeAlso":["http://www.allerganclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":38},"commonTop":["Urinary tract infection","Bacteriuria","Headache","Leukocyturia","Diarrhoea"]}}